Initiating a collaborative partnership between large pharma and a startup can increase the likelihood of funding and an eventual exit.
During this robust discussion, we will highlight the structure of an optimal term sheet with a particular focus on:
- Optimized upfront payments
- Milestones pre/post commercial sale
- Royalty Structuring
Featuring:
Anton Xavier, Director, Startup Banking Life Sciences at Silicon Valley Bank Financial Group
Additional speakers to be announced
Brought to you by Cure by Deerfield
The Cure at 345 Park Avenue South, leading life science, digital health, and tech-enabled companies from across the world come together to uncover cutting-edge solutions for those in need. We provide laboratories, engineering and computing space, and other amenities and supportive services to help today’s thought leaders build a better tomorrow.